299 related articles for article (PubMed ID: 29861166)
1. The Impact of APP on Alzheimer-like Pathogenesis and Gene Expression in Down Syndrome iPSC-Derived Neurons.
Ovchinnikov DA; Korn O; Virshup I; Wells CA; Wolvetang EJ
Stem Cell Reports; 2018 Jul; 11(1):32-42. PubMed ID: 29861166
[TBL] [Abstract][Full Text] [Related]
2. A human stem cell model of early Alzheimer's disease pathology in Down syndrome.
Shi Y; Kirwan P; Smith J; MacLean G; Orkin SH; Livesey FJ
Sci Transl Med; 2012 Mar; 4(124):124ra29. PubMed ID: 22344463
[TBL] [Abstract][Full Text] [Related]
3. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
[TBL] [Abstract][Full Text] [Related]
4. Cerebral organoids with chromosome 21 trisomy secrete Alzheimer's disease-related soluble aggregates detectable by single-molecule-fluorescence and super-resolution microscopy.
Fertan E; Böken D; Murray A; Danial JSH; Lam JYL; Wu Y; Goh PA; Alić I; Cheetham MR; Lobanova E; Zhang YP; Nižetić D; Klenerman D
Mol Psychiatry; 2024 Feb; 29(2):369-386. PubMed ID: 38102482
[TBL] [Abstract][Full Text] [Related]
5. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
[TBL] [Abstract][Full Text] [Related]
6. Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.
García-Cerro S; Rueda N; Vidal V; Lantigua S; Martínez-Cué C
Neurobiol Dis; 2017 Oct; 106():76-88. PubMed ID: 28647555
[TBL] [Abstract][Full Text] [Related]
7. The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons.
Muratore CR; Rice HC; Srikanth P; Callahan DG; Shin T; Benjamin LN; Walsh DM; Selkoe DJ; Young-Pearse TL
Hum Mol Genet; 2014 Jul; 23(13):3523-36. PubMed ID: 24524897
[TBL] [Abstract][Full Text] [Related]
8. A Large Panel of Isogenic APP and PSEN1 Mutant Human iPSC Neurons Reveals Shared Endosomal Abnormalities Mediated by APP β-CTFs, Not Aβ.
Kwart D; Gregg A; Scheckel C; Murphy EA; Paquet D; Duffield M; Fak J; Olsen O; Darnell RB; Tessier-Lavigne M
Neuron; 2019 Oct; 104(2):256-270.e5. PubMed ID: 31416668
[TBL] [Abstract][Full Text] [Related]
9. Endoplasmic reticulum stress induces Alzheimer disease-like phenotypes in the neuron derived from the induced pluripotent stem cell with D678H mutation on amyloid precursor protein.
Devina T; Wong YH; Hsiao CW; Li YJ; Lien CC; Cheng IH
J Neurochem; 2022 Oct; 163(1):26-39. PubMed ID: 35943292
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcysteine prevents amyloid-β secretion in neurons derived from human pluripotent stem cells with trisomy 21.
Toshikawa H; Ikenaka A; Li L; Nishinaka-Arai Y; Niwa A; Ashida A; Kazuki Y; Nakahata T; Tamai H; Russell DW; Saito MK
Sci Rep; 2021 Aug; 11(1):17377. PubMed ID: 34462463
[TBL] [Abstract][Full Text] [Related]
11. Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.
Dashinimaev EB; Artyuhov AS; Bolshakov AP; Vorotelyak EA; Vasiliev AV
J Alzheimers Dis; 2017; 56(2):835-847. PubMed ID: 28059787
[TBL] [Abstract][Full Text] [Related]
12. Probing sporadic and familial Alzheimer's disease using induced pluripotent stem cells.
Israel MA; Yuan SH; Bardy C; Reyna SM; Mu Y; Herrera C; Hefferan MP; Van Gorp S; Nazor KL; Boscolo FS; Carson CT; Laurent LC; Marsala M; Gage FH; Remes AM; Koo EH; Goldstein LS
Nature; 2012 Jan; 482(7384):216-20. PubMed ID: 22278060
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease.
Brownjohn PW; Smith J; Portelius E; Serneels L; Kvartsberg H; De Strooper B; Blennow K; Zetterberg H; Livesey FJ
Stem Cell Reports; 2017 Apr; 8(4):870-882. PubMed ID: 28285880
[TBL] [Abstract][Full Text] [Related]
14. Fyn Tyrosine Kinase Elicits Amyloid Precursor Protein Tyr682 Phosphorylation in Neurons from Alzheimer's Disease Patients.
Iannuzzi F; Sirabella R; Canu N; Maier TJ; Annunziato L; Matrone C
Cells; 2020 Jul; 9(8):. PubMed ID: 32751526
[TBL] [Abstract][Full Text] [Related]
15. Efficient manipulation of gene dosage in human iPSCs using CRISPR/Cas9 nickases.
Ye T; Duan Y; Tsang HWS; Xu H; Chen Y; Cao H; Chen Y; Fu AKY; Ip NY
Commun Biol; 2021 Feb; 4(1):195. PubMed ID: 33580208
[TBL] [Abstract][Full Text] [Related]
16. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
[TBL] [Abstract][Full Text] [Related]
17. BACE1 elevation engendered by GGA3 deletion increases β-amyloid pathology in association with APP elevation and decreased CHL1 processing in 5XFAD mice.
Kim W; Ma L; Lomoio S; Willen R; Lombardo S; Dong J; Haydon PG; Tesco G
Mol Neurodegener; 2018 Feb; 13(1):6. PubMed ID: 29391027
[TBL] [Abstract][Full Text] [Related]
18. Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein.
Gomez W; Morales R; Maracaja-Coutinho V; Parra V; Nassif M
Aging (Albany NY); 2020 Jan; 12(1):1011-1033. PubMed ID: 31918411
[TBL] [Abstract][Full Text] [Related]
19. Lysosomal Dysfunction in Down Syndrome Is APP-Dependent and Mediated by APP-βCTF (C99).
Jiang Y; Sato Y; Im E; Berg M; Bordi M; Darji S; Kumar A; Mohan PS; Bandyopadhyay U; Diaz A; Cuervo AM; Nixon RA
J Neurosci; 2019 Jul; 39(27):5255-5268. PubMed ID: 31043483
[TBL] [Abstract][Full Text] [Related]
20. Depletion of the AD Risk Gene SORL1 Selectively Impairs Neuronal Endosomal Traffic Independent of Amyloidogenic APP Processing.
Knupp A; Mishra S; Martinez R; Braggin JE; Szabo M; Kinoshita C; Hailey DW; Small SA; Jayadev S; Young JE
Cell Rep; 2020 Jun; 31(9):107719. PubMed ID: 32492427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
